A North Texas woman with a cautionary tale warns others to do their research before starting popular weight loss drugs.

ITV News Health Correspondent Rebecca Barry and Senior Producer Liz Little investigate the “lethal” skinny jab black market.

Adult patients taking Wegovy saw a reduced risk of experiencing a major adverse cardiovascular event within the first three months of treatment, according to a secondary analysis of the drug’s ...

What to eat to mimic the effects of Ozempic, without the jabs - Certain nutrients and dietary strategies can raise levels of ...

Limited effectiveness, weight regain, and high prevalence of adverse events are the three key limitations of semaglutide ...

While natural approaches to raising GLP-1 are not as potent as medications, they provide a drug-free approach to weight loss ...

U.S.-based Waters Corp , which makes medical equipment used in clinical testing, has seen a spurt in demand from drugmakers ...

As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 ...

Less than 3% of all people in the U.S. who are eligible for injectable weight loss drugs get a prescription for it, a new ...

A digital obesity clinic, Embla, is associated with 16.7% weight loss over 64 weeks, matching previous semaglutide trial ...

Novo Nordisk's current product portfolio is well-protected by patents until at least 2030. Click here to see why NVO stock is ...

The research collaboration, under which Septerna will receive more than $200 million in upfront and near-term fees, is the ...